Genenta Science SPA
NASDAQ:GNTA
Genenta Science SPA
NASDAQ:GNTA
Price:
0.865
USD
-1.7%
Market Closed
Market Cap:
$16.6m
Cash Flow Statement
Cash Flow Statement
Genenta Science SPA
Genenta Science SPA
Currency: EUR
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(6)
|
(4)
|
(8)
|
(13)
|
(12)
|
(9)
|
(9)
|
(9)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Change in Working Capital |
(2)
|
(2)
|
0
|
(0)
|
(0)
|
3
|
2
|
(2)
|
|
| Cash from Operating Activities |
(7)
N/A
|
(5)
+31%
|
(7)
-53%
|
(12)
-68%
|
(11)
+10%
|
(6)
+49%
|
(6)
-10%
|
(10)
-55%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
(10)
|
(15)
|
(1)
|
7
|
(2)
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-28%
|
(0)
-134%
|
(10)
-33 319%
|
(15)
-49%
|
(1)
+96%
|
7
N/A
|
(2)
N/A
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
29
|
29
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Cash from Financing Activities |
29
N/A
|
29
+1%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+54 180%
|
0
0%
|
10
+3 768%
|
|
| Change in Cash | |||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
|
| Net Change in Cash |
22
N/A
|
24
+11%
|
(7)
N/A
|
(22)
-201%
|
(26)
-16%
|
(6)
+77%
|
1
N/A
|
(1)
N/A
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(7)
N/A
|
(5)
+30%
|
(7)
-54%
|
(12)
-67%
|
(11)
+10%
|
(6)
+49%
|
(6)
-10%
|
(10)
-55%
|
|
Switch to:
Switch to:
See Also
Discover More
